IFG Advisory’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,926
Closed -$258K 449
2020
Q3
$258K Sell
6,926
-4,020
-37% -$148K 0.04% 348
2020
Q2
$376K Hold
10,946
0.07% 258
2020
Q1
$306K Sell
10,946
-1,038
-9% -$34.6K 0.07% 262
2019
Q4
$416K Sell
11,984
-838
-7% -$28.3K 0.08% 262
2019
Q3
$413K Sell
12,822
-779
-6% -$26.6K 0.08% 256
2019
Q2
$466K Hold
13,601
0.08% 214
2019
Q1
$455K Buy
13,601
+221
+2% +$6.96K 0.09% 211
2018
Q4
$369K Sell
13,380
-492
-4% -$15.3K 0.09% 219
2018
Q3
$533K Buy
13,872
+1,678
+14% +$61.7K 0.1% 197
2018
Q2
$428K Buy
12,194
+3,585
+42% +$125K 0.09% 218
2018
Q1
$286K Buy
+8,609
New +$293K 0.06% 278

Other funds holding FFTY

IFG Advisory's FFTY Position: Q4 2020 in Review

IFG Advisory sold out of CapForce IBD 50 ETF (FFTY) in Q4 2020, closing a stake of 6,926 shares — an estimated $258K sold.

IFG Advisory first reported a position in FFTY in Q1 2018 and held it in 11 quarters. The position peaked at $533K in Q3 2018. 64 funds tracked by Wall St. Rank hold FFTY as of Q4 2020.

  • IFG Advisory reported no remaining CapForce IBD 50 ETF position as of Q4 2020 after selling out during the quarter.
  • IFG Advisory sold 6,926 CapForce IBD 50 ETF shares in Q4 2020, an estimated $258K.
  • IFG Advisory first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 11 quarters.
  • IFG Advisory's CapForce IBD 50 ETF position peaked at $533K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2020.

Based on IFG Advisory's 13F filing for Q4 2020, filed 8 Feb 2021.